Get the Stockscreener App
1.48
0.68%
0.01
Intelligent Bio Solutions Inc stock is traded at $1.48, with a volume of 96,078.
It is up +0.68% in the last 24 hours and down -34.22% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
See More
Previous Close:
$1.47
Open:
$1.47
24h Volume:
96,078
Relative Volume:
0.59
Market Cap:
$10.23M
Revenue:
$3.19M
Net Income/Loss:
$-10.42M
P/E Ratio:
-0.0417
EPS:
-35.4757
Net Cash Flow:
$-10.65M
1W Performance:
+0.68%
1M Performance:
-34.22%
6M Performance:
-33.03%
1Y Performance:
+30.40%
1-Day Range:
$1.432
$1.515
1-Week Range:
$1.375
$1.54
52-Week Range:
$1.0701
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.48 | 11.15M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio : Investor Deck - MarketScreener
Intelligent Bio : Fourth Quarter 2025 Fiscal Fourth Quarter 2025 Press Release - MarketScreener
Intelligent Bio Solutions Inc. shares rise 2.00% intraday after Bio-Works' largest shareholders plan to exercise warrants. - AInvest
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July - The Manila Times
Record-Breaking 12,500 Units: Intelligent Bio Solutions Hits All-Time High in Drug Test Cartridge Sales - Stock Titan
Intelligent Bio Solutions Inc. shares rise 2.72% intraday after Bio-Works CEO and board members plan to exercise warrants. - AInvest
Intelligent Bio Solutions' Earnings Turnaround: A Deep Dive into a Biotech Rebound Opportunity - AInvest
Intelligent Bio Solutions FY 2025 Earnings: US$2.00 Loss per Share - AInvest
Intelligent Bio Solutions Full Year 2025 Earnings: US$2.00 loss per share (vs US$6.38 loss in FY 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. Hits Oversold Level on RSI Indicator2025 Biggest Moves & Weekly High Return Forecasts - newsyoung.net
Intelligent Bio Solutions: A High-Risk, High-Reward Play on FDA Clearance and Global Drug Testing Expansion - AInvest
Intelligent Bio 2025 Q4 Earnings Mixed Results with Narrowed Losses - AInvest
Intelligent Bio Solutions reports FY25 EPS ($2.00) vs. ($6.38) last year - TipRanks
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies - The Manila Times
INTELLIGENT BIO SOLUTIONS INC. SEC 10-K Report - TradingView
Intelligent Bio Solutions Reports Q4 16% Revenue Growth, Expands US Market. - AInvest
16% Revenue Growth: Intelligent Bio Solutions Expands to 450+ Customers Across 24 Countries in Drug Testing - Stock Titan
Intelligent Bio Solutions Inc. Nearing Breakout Level After Bounce2025 Short Interest & Momentum Based Trading Signals - kangso.co.kr
Will Intelligent Bio Solutions Inc. Recover After Recent DeclineWeekly Trend Summary & Risk Controlled Daily Plans - mustnews.co.kr
Intelligent Bio Solutions shares rise 1.39% intraday after announcing participation in Sidoti Micro-Cap Virtual Conference. - AInvest
Intelligent Bio Solutions to participate in Sidoti Micro-Cap Virtual Conference. - AInvest
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - MarketScreener
Intelligent Bio Solutions CEO Reveals Growth Strategy at Exclusive Sidoti Conference - Stock Titan
Is Intelligent Bio Solutions Inc. the Top Chart Pick This WeekHigh Win Rate Trading Opportunities Detected - beatles.ru
Intelligent Bio Solutions shares rise 4.52% after-hours after reporting strong Q4 revenue growth and U.S. FDA 510(k) clearance progress. - AInvest
Intelligent Bio Solutions reports double-digit revenue growth in Q4 and FY23. - AInvest
Intelligent Bio Solutions Inc. shares fall 1.28% intraday after reporting preliminary fiscal fourth quarter revenue growth of 16%. - AInvest
Intelligent Bio Solutions Submits Key FDA Information - The Globe and Mail
Intelligent Bio Solutions: A High-Conviction Play on Recurring Revenue and U.S. Market Breakout Potential - AInvest
Intelligent Bio Reports Strong Q4 Revenue Growth and Operational Momentum - TradingView
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - The Manila Times
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Qu - GuruFocus
Intelligent Bio Solutions Expects 16% YoY Growth in Q4 Revenue - AInvest
INBS Expects 16% Q4 Sequential, YoY Revenue Growth, Advances FDA Clearance - AInvest
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 - Yahoo Finance
Intelligent Bio Solutions shares rise 2.56% after-hours after strengthening FDA 510(k) package with new cybersecurity and performance data. - AInvest
Intelligent Bio Solutions submits FDA response for drug screening tech By Investing.com - Investing.com Canada
Intelligent Bio Solutions submits FDA response for drug screening tech - Investing.com
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch - MarketScreener
INBS submits new data to FDA for 510(k) clearance of fingerprint drug screening tech. - AInvest
Intelligent Bio Solutions Strengthens FDA 510(k) Package with Ne - GuruFocus
Intelligent Bio Solutions submits Additional Information to FDA for 510(k) clearance. - AInvest
Massive FDA Data Package: Bio Solutions' Drug Test Aims for Quick Approval After 10,000 Hours of Testing - Stock Titan
Intelligent Bio Solutions Inc. shares rise 2.04% intraday after Eni and LG Chem launch sustainable fuel plant in South Korea. - AInvest
What drives Intelligent Bio Solutions Inc. stock priceFree Technical Analysis Support - Jammu Links News
When is Intelligent Bio Solutions Inc. stock expected to show significant growthInvest like a pro with expert recommendations - Jammu Links News
What catalysts could drive Intelligent Bio Solutions Inc. stock higher in 2025Invest smarter with actionable stock recommendations - Jammu Links News
What institutional investors are buying Intelligent Bio Solutions Inc. stockGet real-time alerts on high-potential stocks - Jammu Links News
Why Intelligent Bio Solutions Inc. stock attracts strong analyst attentionLow Risk Swing Trade Opportunities Identified - beatles.ru
Should I hold or sell Intelligent Bio Solutions Inc. stock in 2025Find market-beating stocks for your portfolio - Jammu Links News
Does Intelligent Bio Solutions Inc. stock perform well during market downturnsUnlock expert trading strategies for growth - Jammu Links News
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):